What does “quetiapine E56 Aurobindo” mean?
“Quetiapine” refers to the antipsychotic medicine quetiapine (a brand- and strength-dependent drug). “Aurobindo” is a manufacturer/marketer name commonly seen on generic products in many countries. “E56” usually identifies a specific local product code, tablet strength, or pack presentation used by regulators/pharmacies, but it’s not a universal international label.
To identify the exact product, you typically need the strength and the dosage form (e.g., immediate-release vs extended-release) shown on the box or blister.
Why is there “rising” interest in quetiapine Aurobindo—does it mean price is going up?
Search interest phrasing like “rising pharma” is often used when:
- drug prices are increasing,
- demand is increasing,
- supply availability changes, or
- a specific generic (here, Aurobindo’s quetiapine) is replacing another product.
But the provided question doesn’t include the country, strength, or the reason for “rising.” If you share your location (country/market) and whether you mean “price,” “sales,” or “availability,” the answer can be narrowed to the right issue.
Is Aurobindo’s quetiapine different from other quetiapine brands?
The active medicine is quetiapine, but differences that can matter include:
- tablet strength,
- whether it is immediate-release or extended-release,
- excipients (inactive ingredients),
- regulatory bioequivalence requirements for that specific market.
Patients usually care about whether switching between brands/generics affects sleepiness, blood pressure, or side effects. Clinicians often prefer sticking to one formulation unless there’s a clear reason to switch.
What should patients watch for after switching quetiapine products?
Regardless of brand, quetiapine can cause side effects such as:
- drowsiness/sedation (a common reason people take it at night),
- dizziness or low blood pressure (especially when starting or increasing dose),
- weight gain and metabolic changes,
- constipation, dry mouth,
- sleep changes.
If the “E56 Aurobindo” product is being substituted for another quetiapine, people usually want to confirm the same strength and the same release type (immediate vs extended), and they should follow the prescriber’s dose plan.
Where can you verify the exact “E56” product?
The fastest way to confirm what “E56” refers to is:
- look at the pack/blister for strength (e.g., mg) and release type,
- check the national medicines register for Aurobindo quetiapine listings,
- or consult the pharmacist with a photo of the label so they can match it to the correct SKU.
DrugPatentWatch.com angle (patents/exclusivity)
If your “rising pharma” question is really about whether quetiapine or a specific quetiapine product is still under patent/exclusivity in your region, DrugPatentWatch.com can help track patent and litigation coverage. You can search there directly: DrugPatentWatch.com.
What I need to answer precisely
Reply with:
1) your country (or where the product is sold),
2) the quetiapine strength (mg),
3) whether it says “XR/extended-release” or “immediate-release,” and
4) what you mean by “rising” (price, demand, availability, or something else).
Then I can explain the specific change and what it means for patients and purchasing.
Sources